Not when you've got disobedient kids visiting websites you'd rather be off limits. Not when they're streaming videos on Netflix or YouTube when they should be doing their homework. And certainly not when they know more about tech than you do.
But it's not just about your brat's insubordination.
Did you ever stop to consider just how many devices in the house are arm-wrestling with one another for bandwidth? Sure there's the obvious ones ��computers, tablets, smartphones. But then you also have media boxes and entertainment consoles, some mix of Apple TV, Chromecast, DVR, Roku, PlayStation and Xbox. It doesn't end there. You've got light switches and thermostats that connect to the Internet, and even own a bathroom scale that communicates via Wi-Fi.
Top Net Payout Yield Stocks To Invest In Right Now: Aurubis AG (NDA)
Aurubis AG is a Germany-based company engaged in the production of primary copper and precious metals, the recycling of secondary raw materials and the processing of copper into final products. It operates through three business segments: Primary Copper that unifies activities related to the production of marketable copper cathodes from the primary raw material, copper concentrates, as well as the production and marketing of sulfuric acid; Recycling/Precious Metals, engaged in the production of copper cathodes from a variety of recycled raw materials and such by-metals and co-products as gold, silver, platinum and tin, among others, and Copper Products that includes the provision of such copper products as cast wire rod from cathodes, strips, shaped wires and others. The Company operates also through subsidiaries located in Germany, Sweden, the United States, Hong Kong, Russia and Bulgaria, among others. Advisors' Opinion:- [By Corinne Gretler]
Nordea (NDA) dropped 2.6 percent to 77.15 kronor, the biggest decline in four weeks. Sweden sold 284 million shares for 76 kronor each, valuing the 7 percent stake at 21.6 billion kronor ($3.4 billion).
- [By Ruth David]
Block sales in western Europe reached $31.8 billion in the three months through September as Groupama SA sold shares in Societe Generale (GLE) SA and Sweden exited a stake in Nordea Bank (NDA) AB, data compiled by Bloomberg show. At the same time, investors poured about $22.2 billion into the region�� stock funds in the 15 weeks through Oct. 9, according to data from research firm EPFR Global Inc.
Top Net Payout Yield Stocks To Invest In Right Now: Nestle SA (NSRGY.PK)
Nestle SA is a company engaged in the nutrition, health and wellness sectors. It is the holding company of the Nestle Group, which comprises subsidiaries, associated companies and joint ventures throughout the world. The Company has such business units as Food and Beverage, Nestle Waters and Nestle Nutrition. Nestle is also active in the pharmaceutical sector. It divides its products into nine categories: Prepared dishes and cooking aids, Beverages, Confectionery, Ice cream, Water, PetCare, Milk products, Nutrition and Pharma. It has numerous subsidiaries engaged in various areas of activity, including Alcon Ophthalmika GmbH (Austria), Alcon Bulgaria EOOD (Bulgaria) and Galderma Laboratorium GmbH (Germany) for pharmaceuticals; Novartis Nutrition GmbH (Austria) and Hjem-IS A/S (Denmark) for food and beverages, and Galderma International SAS (France) and Galderma Laboratorium GmbH (Germany) for health and beauty activities. The Company is headquartered in Vevey, Switzerland. In July 2008, Novartis AG acquired a 25% stake in Alcon, Inc. from Nestle SA. In March 2010, the Company acquired Kraft Foods Inc' frozen pizza business.
In April 2008, L'Oreal and Nestle SA's joint venture, Galderma Pharma S.A., announced that its United States holding company, Galderma Laboratories, Inc., had acquired approximately 97% interest in CollaGenex Pharmaceuticals, Inc. During the year ended December 31, 2004, Nestle had 500 factories in 83 countries around the world. In 2004, 15 factories were acquired or opened and 29 closed or divested.
Advisors' Opinion:- [By Ong Kang Wei]
And that, unmistakably, is a brand. Although the value of a brand is intangible and cannot be measured in dollars, it is one of the most valuable assets a company can have. This is what differentiates a product from Coca-Cola (KO), Kraft Foods Group (KRFT), Nestle (NSRGY.PK) or McDonald's (MCD) from just another unknown manufacturer of these very much essential goods and services. In my eyes, brands are as good as a promise to consumers, which differentiates the product from the rest, and promises that the standard of that certain product will be much better than that of another manufacturer. Without this brand that people trust in and are loyal to, there will not be substantial profits and future growth for the company. Do you think Warren Buffett would have bought out Heinz (HNZ) without its world-famous brand name? Definitely not! It would be as good as just another ketchup brand left on the shelf.
- [By Tim McAleenan Jr.]
I do not mention these things to discourage you from international stocks. I have been purchasing BP (BP) between $39-$43, and I will eventually purchase Anheuser-Busch (BUD), Nestle (NSRGY.PK), Royal Dutch Shell (RDS.B), and two or three other international companies when the stars line up. My point is that you should not feel an obligation to own international stocks simply for diversification's sake. If you find a good international stock with a business model you understand and it trades at an attractive price, then great. You should buy it. But owning international stocks does not have to be a necessary part of your strategy. Despite what Mankiw advises in the New York Times, you can build a diversified collection of "global stocks" simply by investigating where certain American multinationals generate the bulk of their sales and earnings.
Hot Logistics Stocks To Watch Right Now: Echo Therapeutics Inc (ECTE)
Echo Therapeutics, Inc. (Echo), incorporated on September 10, 2007, is a transdermal medical device company. The Company is developing Prelude SkinPrep System (Prelude) as a technology to allow for painless and skin permeation that enable both analyte extraction and needle-free drug delivery. The Company is developing its Symphony CGM System (Symphony) as a non-invasive, wireless continuous glucose monitoring (CGM) system for use in hospital critical care units and for people with diabetes. The Prelude SkinPrep System (Prelude), a component of its Symphony CGM System, allows for skin permeation that enables extraction of analytes such as glucose. Prelude�� platform skin preparation technology also allows for needle-free, transdermal drug delivery.
Symphony CGM System
The Symphony CGM System incorporates a Prelude skin preparation device, transdermal sensor, wireless transmitter and data display monitor. When the electro-chemical glucose sensor is placed on the prepared site, it uses glucose oxidase to generate a continuous current that is proportional to the concentration of blood glucose in the vessels beneath the epidermis. The signals are then wirelessly transmitted to a remote monitor. The monitor, calibrated periodically with a reference blood glucose measurement, converts the data to a glucose measurement based on the reference value. The monitor displays glucose readings and also contains customizable early-warning alarms for hypo- or hyperglycemia.
Prelude SkinPrep System
The Company is developing Prelude as a transdermal skin preparation device for Symphony to improve the access to the interstitial fluids and the flow of molecules across the protective membrane of the stratum corneum, the outmost protective layer of the skin. Prelude incorporates the Company's skin abrasion control technology into a hand-held device used to prepare a small area of the skin. The non-invasive sensor is applied to this prepared area in order to measure the in! terstitial glucose levels.
Specialty Pharmaceuticals
The Company�� specialty pharmaceuticals pipeline is based on itsAzone transdermal drug reformulation technology. AzoneTS is a nontoxic, nonirritating skin penetration that is intended to enable topical application of food and drug administration (FDA) -approved drugs, including pharmaceutical products that previously could only be administered systemically. Its advanced drug candidate is Durhalieve, an AzoneTS formulation of triamcinolone acetonide, medium potency corticosteroid approved by the FDA for treatment of corticosteroid-responsive dermatoses. AzoneTS increases lipid membrane fluidity in the stratum corneum layer of the skin, thereby decreasing resistance to topically applied therapeutics.
The Company competes with Roche, Johnson & Johnson, Bayer, Abbott Laboratories , DexCom, Inc., Medtronic, Inc., Edwards Lifesciences Corporation, Optiscan Biomedical Corp., Medtronic, Glysure, Glumetrics Inc., Maquet and A. Menarini Diagnostics S.r.l.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 health care player that's quickly moving within range of triggering a major breakout trade is Echo Therapeutics (ECTE), which is a transdermal medical device company with skin permeation technology. This stock has been destroyed by the bears so far in 2013, with shares off huge by 70%.
If you take a look at the chart for Echo Therapeutics, you'll notice that this stock has been uptrending strong for the last month, with shares moving higher from its low of $2.14 to its intraday high of $3.06 a share. During that uptrend, shares of ECTE have been consistently making higher lows and higher highs, which is bullish technical price action. That move has pushed shares of ECTE back above its 50-day moving average at $2.65 a share, and it's just starting to push ECTE into breakout territory, since the stock has cleared some key near-term overhead resistance levels at $2.98 to $2.99 a share. That move is quickly pushing shares of ECTE within range of triggering an even bigger breakout trade.
Market players should now look for long-biased trades in ECTE if it manages to break out above some major near-term overhead resistance at $3.30 a share with high volume. Look for a sustained move or close above that level with volume that registers near or above its three-month average volume of 211,103 shares. If that breakout triggers soon, then ECTE will set up to re-test or possibly take out its next major overhead resistance levels at $4 to $4.50 a share, or possibly even $5 to $6 a share.
Traders can look to buy ECTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $2.65 a share, or right below more near-term support at $2.50 a share. One can also buy ECTE off strength once it clears $3.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Bryan Murphy]
Truth be told, Echo Therapeutics Inc. (NASDAQ:ECTE) doesn't look like a particularly impressive stock right now. At $2.92 per share, ECTE is just trading right around where it was a few days ago, not to mention a few weeks ago. And, without any real "news" from the company in months, it's tough to think the market's going to be getting excited about the stock anytime soon. When you take a closer look at Echo Therapeutics though, a few subtle-but-compelling clues start to appear.
Top Net Payout Yield Stocks To Invest In Right Now: IntriCon Corporation(IIN)
IntriCon Corporation, through its subsidiaries, engages in the design, development, engineering, and manufacture of body-worn devices. It offers microelectronics, micro-mechanical assemblies, and injection-molded plastic components to medical device manufacturers of portable and lightweight battery powered devices; bio-telemetry devices, which include wireless continuous glucose monitors that measure glucose levels and provide real-time blood glucose trend information; and cardiac diagnostic monitoring devices. The company also provides bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and a family of safety needle products for original equipment manufacturing customers. In addition, it offers hybrid amplifiers and integrated circuit components along with faceplates for use in-the-ear and in-the-canal hearing instruments; and microminiature electromechanical components consisting of volume controls, microphone s, receivers, trimmer potentiometers, and switches to hearing instrument manufacturers. Further, the company provides professional audio headset products used for homeland security and emergency response applications in fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear and head-worn devices for use by performers and support staff in music and stage performance markets. It markets its products directly through its internal sales force in the United States, as well as through sales representative primarily in Europe and the Asian Pacific. IntriCon Corporation has strategic alliances with Dynamic Hearing Pty Ltd. to use its technology for the development of new body-worn ULP-DSP applications; and Advanced Medical Electronics Corp. to develop new bio-telemetry devices. The company, formerly known as Selas Corporation of America, was founded in 1930 and is headquartered in Arden Hills, Minnesota.
Advisors' Opinion:- [By Lisa Levin]
Intricon (NASDAQ: IIN) shares gained 33.98% to touch a new 52-week high of $6.23 after the company reported Q1 results.
Abraxas Petroleum (NASDAQ: AXAS) shares gained 2.19% to reach a new 52-week high of $5.60. Abraxas Petroleum shares have jumped 154.88% over the past 52 weeks, while the S&P 500 index has gained 18.57% in the same period.
Top Net Payout Yield Stocks To Invest In Right Now: Griffin Land & Nurseries Inc.(GRIF)
Griffin Land & Nurseries, Inc., together with its subsidiaries, engages in real estate and landscape nursery businesses in the United States. The company?s real estate business consists of the ownership, construction, leasing, and management of commercial and industrial properties, as well as the development of residential subdivisions on real estate owned by it in Connecticut, Massachusetts, and Pennsylvania. Its landscape nursery business comprises the growing of containerized plants for sale principally to independent retail garden centers, rewholesalers, mass merchandisers, home centers, and landscape contractors. Griffin Land & Nurseries, Inc. was founded in 1970 and is based in New York City, New York.
Advisors' Opinion:- [By Dividends4Life]
Memberships and Peers: ADM is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: Bunge Limited (BG) with a 1.6% yield, Ingredion Incorporated (INGR) with a 2.4% yield and Griffin Land & Nurseries Inc. (GRIF) with a 0.7% yield.
Top Net Payout Yield Stocks To Invest In Right Now: Akorn Inc.(AKRX)
Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. It offers products in various specialty areas, including ophthalmology, antidotes, anti-infectives, pain management, anesthesia, and vaccines. The company?s Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, angiography dyes, and others primarily for use in the office setting. This segment also offers therapeutic products, such as antibiotics, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers; and non-pharmaceutical products, which include various artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers. In addit ion, the Ophthalmic segment provides a line of over-the-counter dry eye and other eye health products principally under the TheraTears brand name through a chain drug stores and big box retailers, as well as directly to optometrists, ophthalmologists, and other eye care practitioners and clinics. The company?s Hospital Drugs and Injectables segment provides a line of niche hospital drug and injectable pharmaceutical products comprising antidotes, anti-infectives, controlled substances for pain management and anesthesia, and other pharmaceutical products to hospitals through the wholesale distribution channel. Its Contract Services segment manufactures ophthalmic and injectable pharmaceutical products for third party pharmaceutical customers based on their specifications. The company serves physicians, optometrists, hospitals, wholesalers, group purchasing organizations, pharmacy chains, and other pharmaceutical companies. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Akorn (NASDAQ: AKRX) were down 9.41 percent to $23.39 after the company reported Q4 results and issued a weak FY14 guidance. - [By Ben Levisohn]
Still, some stocks are bucking the trend. Goodyear Tire & Rubber (GT) has gained 1.4% to $18.90, the largest gainer in the S&P 500, after reaching a deal with a union. The real winners: Hi-Tech Pharmacal (HITK) has gained 22.3% to $43.05 after agreeing to be purchased by Akorn (AKRX), which has jumped 9.6% to $18.02.
- [By Sean Williams]
What: Shares of Akorn (NASDAQ: AKRX ) �-- a hybrid generic and branded drug developer -- shed as much as 15% of their value after the company reported disappointing first-quarter results.
Top Net Payout Yield Stocks To Invest In Right Now: International Tower Hill Mines Ltd (THM)
International Tower Hill Mines Ltd. (ITH) is an exploration-stage company. The Company is engaged in the business of acquiring, exploring and evaluating mineral properties, and either joint venturing or developing these properties further or disposing of them when the evaluation is completed. As of December 31, 2011, the Company controlled a 100% interest in its Livengood project in Alaska, the United States. The Livengood property is located approximately 115 kilometers northwest of Fairbanks, Alaska in the Tolovana Mining District within the Tintina Gold Belt. The property is approximately 145 square kilometers and consists of fee land leased from the Alaska Mental Health Trust. The project area is centered on Money Knob. Advisors' Opinion:- [By Bryan Murphy]
With no revenues, and therefore no profits, International Tower Hill Mines Ltd (NYSEMKT:THM) shouldn't qualify as "investment worthy" in any way, shape, or form. Indeed, the near-100% loss that THM shares have suffered since early 2011 might scare off even the gutsiest of traders. Yet, there's something undeniably bullish about this stock right now.
- [By Holly LaFon]
He increased his holdings in gold companies in the fourth quarter accordingly. Gold stocks he found attractive in the fourth quarter are: Novagold Resources (NG), Randgold Resources (GOLD), Iamgold Corp. (IAG), Barrick Gold Corp. (ABX), Agnico Eagle (AEM) and International Tower Hill (THM).
- [By Anthony Mirhaydari]
For now, I continue to recommend investors maintain a cautious stance, focusing on the buying interest coming into safe-haven assets like U.S. Treasury bond and precious metals while booking profits in biotech stocks that have been red hot this month. The leveraged Direxion 3x Treasury Bond Bull (TMF) is up nearly 7% in my Edge Letter Sample Portfolio since it was added on Jan. 10. I just sold Tower Hill Mines (THM) and Rosetta Genomics (ROSG) for gains of 46% and 18% respectively.
Top Net Payout Yield Stocks To Invest In Right Now: Noble Energy Inc. (NBL)
Noble Energy, Inc., through its subsidiaries, engages in the acquisition, exploration, development, production, and marketing of crude oil, natural gas, and natural gas liquids in the United States, West Africa, Eastern Mediterranean, the North Sea, and internationally. Its principal projects include the Central DJ Basin properties in the onshore US; Galapagos and Gunflint projects in the deepwater Gulf of Mexico; Tamar project in the offshore Israel; Aseng, Alen, and Diega/Carmen projects in the offshore Equatorial Guinea; and West Africa gas projects located in the offshore Equatorial Guinea and Cameroon. The company was founded in 1932 and is based in Houston, Texas.
Advisors' Opinion:- [By Ben Levisohn]
We believe Anadarko Petroleum offers investors a better-than-average portfolio with attractive high-potential deepwater program and solid onshore assets, particularly the dominant position in the Niobrara and an exciting position in the emerging Delaware Basin. When you also consider the track record of solid deep water exploration success, the willingness to monetize assets, the large discovery in Mozambique and the $10-billion interest in GPM it is easy to understand investor enthusiasm. When we contrast�Anadarko Petroleum’s delivery in comparison to several of its better positioned peers we find better value elsewhere in the group. We believe Continental Resources (CLR), EOG Resources (EOG) and Noble Energy (NBL) are all likely to grow twice as fast as Anadarko Petroleum ��yet there is no appreciable premium in any of those shares. Debt-adjusted cash-flow multiples using 2015 estimates are 7.6x, 6.1x and 7.2x for the peers Continental Resources, EOG Resources, and Noble Energy, respectively, as compared to�Anadarko Petroleum’s 7.3x.
Top Net Payout Yield Stocks To Invest In Right Now: eHealth Inc.(EHTH)
eHealth, Inc. offers Internet-based insurance agency services for individuals, families, and small businesses in the United States. The company also offers technology licensing and Internet advertising services. Its ecommerce platforms organize and present health insurance information in various formats, as well as enables individuals, families, and small businesses to research, analyze, compare, and purchase various health insurance plans. The company offers various medical health insurance coverage plans, such as preferred provider organization, health maintenance organization and indemnity plans, Medicare plans, short-term medical insurance, student health insurance, and health savings account eligible health insurance plans, as well as ancillary plans, such as dental, vision, and life insurance. Its customers access its ecommerce platforms through its Websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, and PlanPrescriber.com, as well as through a network of marketing partners. The company was incorporated in 1997 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Ben Levisohn]
Stocks finished mix today, though it’s probably more fair to say they hardly moved at all.�Intel�(INTC), Facebook (FB) and�Achillion Pharmaceuticals (ACHN) gained, while�CR Bard�(BCR) and eHealth (EHTH) fell.
- [By Sean Williams]
What: Shares of eHealth (NASDAQ: EHTH ) �-- a provider of private market online health insurance services for individuals, families, and small businesses -- jumped as much as 17% after the company reported third-quarter earnings results.
Top Net Payout Yield Stocks To Invest In Right Now: China North East Petroleum Holdings Limited(NEP)
China North East Petroleum Holdings Limited engages in the exploration and production of crude oil in northern China. As of December 31, 2010, it operated 295 producing wells with proven reserves of 5,476,200 barrels of crude oil at Qian?an 112, Hetingbao 301, Daan 34, and Gudian 31 oilfields. The company, through its subsidiary, Song Yuan Tiancheng Drilling Engineering Co., Ltd., provides contract land drilling and other oilfield services for state-owned and non-state-owned oil companies. China North East Petroleum Holdings Limited is headquartered in Song Yuan City, the People?s Republic of China.
Advisors' Opinion:- [By Ben Levisohn]
Krishna and Krauklis note that Buffalo Wild Wings, Nextera Energy (NEP), Rexnord Corp (RXN), and The Advisory Board (ABCO) should benefit from recent acquisitions that should boost revenue growth, while�Buffalo Wild Wings and Cavium (CAVM) should see improvements thanks to the adoption of new technology that will help boost margins. Terex, The Advisory Board, and�Rexnord should get a boost from cost cutting, Krishna and Krauklis say.
No comments:
Post a Comment